HER2 positive breast cancer: Treatment de-escalation needs to be personalized

HER2 positive breast cancer: Treatment de-escalation needs to be personalized

De-escalation approaches in the treatment of women with HER2 positive breast cancer need to be perso...
read more
New England Journal of Medicine Publishes Positive Results of the Pivotal Trial of Cablivi (caplacizumab) for Rare Blood Clotting Disorder

New England Journal of Medicine Publishes Positive Results of the Pivotal Trial of Cablivi (caplacizumab) for Rare Blood Clotting Disorder

PARIS, Jan. 9, 2019 /PRNewswire/ — The New E...
read more